{"answer":"Pioglitazone as monotherapy, dual oral therapy in combination with metformin, and as triple oral therapy in combination with metformin and a sulphonylurea, is indicated as second or third line treatment of type 2 diabetes mellitus. Pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemia control on insulin for whom metformin is inappropriate because of contraindications or intolerance."}